NO882607L - Fremgangsmaate for fremstilling av leukotrienantagonister. - Google Patents

Fremgangsmaate for fremstilling av leukotrienantagonister.

Info

Publication number
NO882607L
NO882607L NO882607A NO882607A NO882607L NO 882607 L NO882607 L NO 882607L NO 882607 A NO882607 A NO 882607A NO 882607 A NO882607 A NO 882607A NO 882607 L NO882607 L NO 882607L
Authority
NO
Norway
Prior art keywords
alkyl
alkoxy
procedure
manufacturing
cor3
Prior art date
Application number
NO882607A
Other languages
English (en)
Other versions
NO882607D0 (no
Inventor
James Simpson Frazee
John Gerald Gleason
Ralph Floyd Hall
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of NO882607D0 publication Critical patent/NO882607D0/no
Publication of NO882607L publication Critical patent/NO882607L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO882607A 1987-06-24 1988-06-14 Fremgangsmaate for fremstilling av leukotrienantagonister. NO882607L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6658887A 1987-06-24 1987-06-24

Publications (2)

Publication Number Publication Date
NO882607D0 NO882607D0 (no) 1988-06-14
NO882607L true NO882607L (no) 1988-12-27

Family

ID=22070455

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882607A NO882607L (no) 1987-06-24 1988-06-14 Fremgangsmaate for fremstilling av leukotrienantagonister.

Country Status (14)

Country Link
EP (1) EP0296732B1 (no)
JP (1) JPS6434955A (no)
CN (1) CN1030074A (no)
AT (1) ATE68176T1 (no)
AU (1) AU620037B2 (no)
CA (1) CA1334200C (no)
DE (1) DE3865373D1 (no)
DK (1) DK327088A (no)
FI (1) FI882866A (no)
HU (1) HU201521B (no)
NO (1) NO882607L (no)
NZ (1) NZ225021A (no)
PT (1) PT87615B (no)
ZA (1) ZA884272B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937253A (en) * 1985-04-19 1990-06-26 Smithkline Beecham Corporation Ester prodrugs
US4954513A (en) * 1988-12-23 1990-09-04 Smithkline Beecham Corporation Leukotriene antagonists
DE3905518A1 (de) * 1989-02-23 1990-10-11 Bayer Ag Substituierte phenoxyphenylpropionsaeure-derivate
CA2018437A1 (en) * 1989-06-14 1990-12-14 James Simpson Frazee Leukotriene antagonists
ATE96149T1 (de) * 1989-07-27 1993-11-15 Bayer Ag Arylalkensaeurederivate als leukotrienantagonisten.
US5266713A (en) * 1989-07-27 1993-11-30 Miles Inc. Aryl alkenoic acid derivatives as leukotriene antagonists
WO1991018889A1 (en) * 1990-06-06 1991-12-12 Smithkline Beecham Corporation Leukotriene antagonists
EP0541706B1 (en) * 1990-08-01 1995-09-13 Smithkline Beecham Corporation Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids
DE19943634A1 (de) 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874792A (en) * 1985-04-19 1989-10-17 Smithkline Beckman Corporation Thiophenyl Alkanoic acids useful as leukotriene antagonists
ATE90330T1 (de) * 1985-04-19 1993-06-15 Smithkline Beecham Corp Zwischenprodukte fuer die herstellung von leukotrien-antagonisten.

Also Published As

Publication number Publication date
NZ225021A (en) 1991-02-26
CN1030074A (zh) 1989-01-04
PT87615B (pt) 1992-09-30
DE3865373D1 (de) 1991-11-14
AU620037B2 (en) 1992-02-13
JPS6434955A (en) 1989-02-06
AU1759588A (en) 1989-01-05
PT87615A (pt) 1988-06-01
NO882607D0 (no) 1988-06-14
EP0296732A1 (en) 1988-12-28
FI882866A (fi) 1988-12-25
ATE68176T1 (de) 1991-10-15
FI882866A0 (fi) 1988-06-15
HU201521B (en) 1990-11-28
DK327088A (da) 1988-12-25
ZA884272B (en) 1989-06-28
EP0296732B1 (en) 1991-10-09
DK327088D0 (da) 1988-06-15
CA1334200C (en) 1995-01-31
HUT47242A (en) 1989-02-28

Similar Documents

Publication Publication Date Title
NO882607L (no) Fremgangsmaate for fremstilling av leukotrienantagonister.
DK709088D0 (da) Hidtil ukendte forbindelser
PT87616A (pt) Process for the preparation of leukotriene antagonists and of pharmaceutical compounds
ES2063271T3 (es) Antagonistas de leucotrienos.
JPS51131870A (en) A process for preparing novel amide compounds
JPS5325533A (en) Novel phenylacetic acid derivatives
YU134591A (sh) Postupak i intermedijer za dobijanje 2-hidroksi-3-sulfido-3- fenilpropionske kiseline
CS292388A2 (en) Herbicide and method of its efficient substance production
NO943548L (no) Fremgangsmåte og mellomprodukter for fremstilling av 2-substituerte benzaldehyder
JPS56139492A (en) Novel schiff base of ampicillin, and its preparation
SE7607044L (sv) Sett att framstella ny malonsyraestrar
JPS55160763A (en) Novel aminoacetal derivative and preparation of tetrahydroisoquinoline derivative comprising it
JPS53127444A (en) Oxime substd. phenylacetic acid derivtives and their preparation
ATE114307T1 (de) Phenylglycidamide, verwendbar in der herstellung von alpha-hydroxy-beta-sulfido-arylpropionsäure- derivaten.